The latest research, 'US Multiple Sclerosis Market Highlights – 2014', provides the US multiple sclerosis market analysis, competitive landscape, and multiple sclerosis drug sales forecast in the US.
The research includes the US multiple sclerosis market size estimates for 2013, market share forecast for six years to 2019, multiple sclerosis drugs market share, multiple sclerosis drugs sales estimates, multiple sclerosis drugs sales forecast, and multiple sclerosis late stage pipeline products.This research helps executives track competitor drugs sales and market share in the US multiple sclerosis market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US multiple sclerosis market.
SCOPE OF THE REPORT
What are the drugs marketed in the US for treating multiple sclerosis?
Identify drugs marketed in the US for treating multiple sclerosis including trade name, molecule name, company, and year of launch.
How big is the US multiple sclerosis market?
Find out estimates for the US multiple sclerosis market size in 2013, key products and their sales, and how the market and products advanced from 2010. You will benefit from our accurate country and indication level valuation of products and the market.
What is my competitor’s drugs market share in the US multiple sclerosis market?
You will know the market share of leading multiple sclerosis brands in the US, including generics share.
What are the key molecules in pipeline for multiple sclerosis?
Find out pipeline products in clinical trial phase 3 and phase 2 for the treatment of multiple sclerosis. Our coverage includes molecule, mechanism of action, and the originator.
What is the future of the US multiple sclerosis market?
Gain insights into how the US multiple sclerosis market will advance along with market forecast till 2019. Determine future market events and trends including launch of new drugs and generic erosion of leading molecules.
Future multiple sclerosis drugs forecast in the US
Find out how multiple sclerosis drugs will be positioned in the US in 2019, with drug sales forecast and drug market share analysis for both marketed products and pipeline products.
Highlights of the Research:
Marketed Multiple Sclerosis Drugs in the US
The US Multiple Sclerosis Market Analysis
Multiple Sclerosis Drugs Sales Analysis in the US
Competitive Landscape in the US Multiple Sclerosis market